Very good post. After approval. Let’s get to $3-4 billion MC then starts from there. If we had couple of P II trials involving L &D we might have seen much higher MC. Unfortunately D has been collecting dust for a long time. But again I will go back to this statement from mgt that we will be a different company by the end of year. Hmmm.
I don’t see this taking 10+ years. The Main reason this is taking so long is because none of the regulators had any guidance in place for a personalized living cell therapy. I believe when we get MHRA approval they will be ready and D will move through the exact same process the exact same way much faster. I’ll guess under 3.
Market Data 
Markets 
AI
